|
|
Beth Israel Deaconess Medical Center Laboratory Manual |
Urgent laboratory values are
test results that are outside normal limits, and that have significant medical
implications for the patient requiring attention and action by the patient’s
providers. A list of tests for which urgent values exist, and the urgent
values themselves, has been established by the BIDMC clinical laboratory,
and are, annually, reviewed, with modifications as needed, and approved by
the Core Clinical Services Committee (CCSC).
The urgent value list:
| Lab |
Section |
Non-critical values
called |
Explanation for Decision to
Call Critical Values/Results |
| Anatomic Pathology |
Physicians will email
clinicians if the cytology is positive for both gyn and non gyn specimens |
Regulatory requirement (CAP) |
|
| Any diagnosis of malignancy
in an uncommon location or specimen type (ie, hernia sac, tonsil intervertebral
disc material), or unexpected clinical situation |
Regulatory requirement (CAP) |
||
| Any definitive diagnosis
of specific infection or other severe medical condition requiring immediate
therapy (ie., temporal arteritis) |
Regulatory requirement (CAP) |
||
| Pathology reports are
sometimes called if requested as a rush case (ie transplant cases) |
Regulatory requirement (CAP) |
||
| Absence of chorionic
villi when clinically expected Regulatory requirement (CAP) |
Regulatory requirement (CAP) | ||
| Any significant discrepancy
between the permanent section and frozen section diagnoses |
Regulatory requirement (CAP) |
||
| Chemistry |
Newly positive HIV
test result (following confirmation by Western Blot Analysis) |
Regulatory requirement (CAP) |
|
| Microbiology |
Stool Culture Bench |
Salmonella |
Public Health Concern |
| Shigella |
Public Health Concern |
||
| Campylobacter |
Public Health Concern |
||
| Yersinia |
Public Health Concern |
||
| Vibrio |
Public Health Concern |
||
| Respiratory Culture
Bench |
Legionella |
Public Health Concern |
|
| Genital Culture Bench |
Neisseria gonorrhoeae
(GC) and Chlamydia trachomatis |
Public Health Concern |
|
| Blood Culture Bench |
Salmonella and other
stool pathogens |
Public Health Concern |
|
| Brucella |
Public Health/CDC select agent |
||
| Francisella tularensis |
Public Health/CDC select agent |
||
| Neisseria gonorrhoeae |
Public Health/CDC select agent |
||
| Neisseria meningitidis |
Public Health/CDC select agent |
||
| Mycology Culture Bench |
Histoplasma |
Extensive delay between specimen
acquisition and final result |
|
| Coccidioides |
Extensive delay between specimen
acquisition and final result |
||
| Blastomyces |
Extensive delay between specimen
acquisition and final result |
||
| Paracoccidioides |
Extensive delay between specimen
acquisition and final result |
||
| Cryptococcus neoformans
(Respiratory sources) |
Extensive delay between specimen
acquisition and final result |
||
| Virology Lab |
Positive DFA for HSV/VZV |
Contact precautions for inpatients |
|
| Positive CMV Early
Antigen |
Might require therapeutic intervention |
||
| Molecular Lab |
Positive Chlamydia
PCR |
Public Health Concern |
|
| Positive Neisseria
gonorrhoeae (GC) |
Public Health Concern |
||
| Positive HIV Viral
Load acute infection |
Public Health Concern |
||
| All areas |
Other results (Select
agents, etc.) on daily rounds that may be considered significant or unusual |
Infection Control and ID called
with id re type of resistance |
|
| Send-outs |
Abnormal maternal screening
results |
Rapid delivery for decision making |
|
| Cytogenetics |
Abnormal prenatal (amniotic
fluid or chorionic villlus) result Abnormal results in certain bone marrow cases New diagnoses of APMLs and other malignancies, and in certain instances of relapse in patients |
Extensive delay between specimen
acquisition and final result |
Revised/Reviewed 2/18/2009